Lidocaine Hcl And Epi
Product Images NDC 51662-1589

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl And Epi (NDC 51662-1589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1589 2 Pouch Label)

Packaging label for XYLOCAINE (Lidocaine HCl and Epi Inj, USP) EPI 1:100,000 1% 500 mg/50 mL (10 mg/mL) 50 mL vial. The label includes NDC 51662-1589-2, lot number, expiration date, usage instructions for infiltration and nerve block, storage information, and manufacturer HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

Case Labeling (51662 1589 3 Case Label)

LIDOCAINE HCl AND EPI 500mg/50mL (10mg/mL) injection vial label. The label indicates it is for infiltration and nerve block, non-cauda equina, non-epidural use. It includes concentration details (EPI 1:100,000 1%), lot and expiration dates, manufacturer HF Acquisition Co LLC. Package size is 50 mL vial, 25 per case.*

FDA Label Image

Serialized Label (51662 1589 3 Serialized Rfid Label)

Packaging label for LIDOCAINE HCl AND EPI, distributed by HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA. The label includes a barcode, serial number, and a note to see the manufacturer's package insert. It also indicates the product is for RX (prescription) use only.*

FDA Label Image

Max Dose (Max Dose)

A data table listing various anatomical locations along with columns for sample doses, vial counts, and total dose in milligrams. The table appears to organize dosage information by site such as infraorbital, maxillary, brachial, and others, with shaded cells highlighting certain values. No proprietary or product-specific information is visible beyond the structured dosing chart.*

FDA Label Image

Precautions (Precautions)

A data table listing drug classes in one column and examples of drugs in the adjacent column. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs with corresponding examples such as nitric oxide, lidocaine, cyclophosphamide, dapsone, chloroquine, Phenobarbital, and acetaminophen.*

FDA Label Image

S1 (Structure 1)

Chemical structure of lidocaine hydrochloride showing its molecular formula with aromatic ring, amide group, and ethyl groups attached to the nitrogen atom, consistent with the active ingredient in LIDOCAINE HCl AND EPI.*

FDA Label Image

S2 (Structure 2)

Chemical structure diagram showing the molecular formula of an active ingredient, featuring a benzene ring with two hydroxyl groups, a side chain with hydroxyl and amine groups, consistent with the structure of epinephrine.*

FDA Label Image

Vial Label (Vial Label)

Xylocaine 1% (Lidocaine HCl and epinephrine injection) with epinephrine 1:100,000, 500 mg per 50 mL (10 mg per mL) in a 50 mL multiple dose vial. The label specifies usage for infiltration and nerve block, not for caudal or epidural use. Manufactured by Fresenius Kabi, the packaging includes storage instructions and safety warnings about avoiding autoclaving due to epinephrine content.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.